Zobrazeno 1 - 10 of 59 pro vyhledávání: '"Haruhito Harada"'
1
Akademický článek
Low serum brain-derived neurotrophic factor may predict poor response to cardiac rehabilitation in patients with cardiovascular disease.
Autor: Yuya Tsukada, Yasuhiro Nishiyama, Michiya Kishimoto, Takeshi Nago, Haruhito Harada, Hiroshi Niiyama, Atsushi Katoh, Hiroo Matsuse, Hisashi Kai
Publikováno v: PLoS ONE, Vol 19, Iss 2, p e0298223 (2024)
BackgroundIt has been shown that serum brain-derived neurotrophic factor (BDNF) is associated with skeletal muscle energy metabolism and that BDNF is a predictor of mortality in heart failure patients. However, little is known about the relationship
Externí odkaz: https://doaj.org/article/23cad7603756487099a196590160eb5b
Zobrazit plný text záznamu
2
Akademický článek
New diagnostic index for sarcopenia in patients with cardiovascular diseases.
Autor: Haruhito Harada, Hisashi Kai, Rei Shibata, Hiroshi Niiyama, Yasuhiro Nishiyama, Toyoaki Murohara, Noriko Yoshida, Atsushi Katoh, Hisao Ikeda
Publikováno v: PLoS ONE, Vol 12, Iss 5, p e0178123 (2017)
Sarcopenia is an aging and disease-related syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, with the risk of frailty and poor quality of life. Sarcopenia is diagnosed by a decrease in skeletal muscle in
Externí odkaz: https://doaj.org/article/6b8230a903a24082bf0a15edb98e899c
Zobrazit plný text záznamu
3
Angiotensin II receptor blocker and statin combination therapy associated with higher skeletal muscle index in patients with cardiovascular disease: A retrospective study
Autor: Hiroshi Niiyama, Haruhito Harada, Yasuhiro Nishiyama, Hisashi Kai, Atsushi Katoh
Publikováno v: Journal of Clinical Pharmacy and Therapeutics. 47:89-96
WHAT IS KNOWN AND OBJECTIVE Reduction in skeletal muscle mass is the most important component in diagnosing sarcopenia. Ageing and chronic heart failure due to cardiovascular diseases (CVDs) accelerate the reduction of skeletal muscles. However, ther
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961e91bb43ae61c978b5e3080b5cfc71
https://doi.org/10.1111/jcpt.13540
Zobrazit plný text záznamu
9
64 Biomarker-based index for detecting sarcopenia in patients with cardiovascular disease
Autor: Hisashi Kai, Atsushi Katoh, Haruhito Harada, N Niiyama
Publikováno v: European Heart Journal. 41
Background Clinical significance of sarcopenia has been highlighted in patients with cardiovascular disease (CVD). Sarcopenia is generally diagnosed based on the decrease in skeletal muscle index (SMI) and the reduction of either handgrip strength or
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db039fae46fc33d951fc045e47b2db4b
https://doi.org/10.1093/ehjci/ehz872.002
Zobrazit plný text záznamu
10
Phenotypic expression of a novel desmin gene mutation: hypertrophic cardiomyopathy followed by systemic myopathy
Autor: Akinori Kimura, Hirofumi Nishi, Yoshinori Koga, Takeharu Hayashi, Ikuya Nonaka, Ken Kusaba, Yasutoshi Koga, Haruhito Harada
Publikováno v: Journal of Human Genetics. 63:249-254
Hypertrophic cardiomyopathy is a heterogeneous disease caused by gene mutations. Most of the disease-causing mutations were found in the genes for sarcomeric proteins, but there are several cases carrying mutations in genes for extra-sarcomeric cytos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f7790a0c584dffbdbe597555de443f7
https://doi.org/10.1038/s10038-017-0383-x
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje